Literature DB >> 31654803

Optimal measuring timing of cystatin C for early detection of contrast-induced acute kidney injury: A systematic review and meta-analysis.

Chu-Ting Chen1, Ling-Yin Chang2, Ching-Wei Chuang1, Shih-Ching Wang1, Ming-Chang Kao3, I-Shiang Tzeng4, Ko-Lin Kuo5, Chin-Chieh Wu6, Pei-Shan Tsai7, Chun-Jen Huang8.   

Abstract

OBJECTIVE: The optimal measuring timing of serum/plasma Cystatin C (CysC) for early detection of contrast-induced acute kidney injury (CIAKI) remains un-studied. We elucidated further on this issue.
METHODS: We searched PubMed, MEDLINE, and Embase from inception until March 2018 for studies evaluating diagnostic accuracy of CysC for detecting CIAKI in patients exposed to contrast agents during diagnostic examinations or cardiac/peripheral catheterizations.
RESULTS: A total of 10 relevant studies, comprising 2554 patients, were included and divided into the <24 -h and 24 -h groups based on CysC measuring timing (i.e., hours after contrast agent exposure). Compared with creatinine, pooled diagnostic odds ratio of CysC for detecting CIAKI of the <24 -h and 24 -h groups was 7.59 (95 % confidence interval [CI]: 1.31-44.08) and 53.81 (95 % CI: 13.57-213.26). Pooled sensitivity of the <24 -h and 24 -h groups was 0.81 and 0.88. Pooled specificity of the <24 -h and 24 -h groups was 0.64 and 0.88, respectively. Area under the hierarchical summary receiver operating characteristic curve of the <24 -h and 24 -h groups was 0.75 and 0.93.
CONCLUSIONS: Measuring CysC at 24 h after contrast agent exposure shows higher diagnostic accuracy for early detection of CIAKI than measuring CysC at <24 h after contrast agent exposure.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AKI; Biomarker; Contrast agent; Creatinine; Cystatin C

Mesh:

Substances:

Year:  2019        PMID: 31654803     DOI: 10.1016/j.toxlet.2019.10.011

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Serum and urinary biomarkers for early detection of acute kidney injury following Hypnale spp. envenoming.

Authors:  Eranga Sanjeewa Wijewickrama; Fahim Mohamed; Indika B Gawarammana; Zoltan H Endre; Nicholas A Buckley; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2021-12-06

Review 2.  Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury.

Authors:  Yiwen Ying; Qian Tang; Da Han; Shan Mou
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.